Nifty
:
25239.10
Sensex
:
82380.69
169.90 (0.68%)
594.95 (0.73%)
Nifty
Sensex
:
:
25239.10
82380.69
169.90 (0.68%)
594.95 (0.73%)

Dishman Carbogen Amcis Ltd.

Pharmaceuticals & Drugs - Global

Rating :
55/99

BSE: 540701 | NSE: DCAL

NSE BSE
266.80
16-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  270.4
  •  273.5
  •  266
  •  267.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  140095
  •  37749775.95
  •  307.98
  •  161.21

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,182.97
  • 40.14
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,759.85
  • N/A
  • 0.71

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 59.32%
  • 1.72%
  • 25.36%
  • FII
  • DII
  • Others
  • 9.94%
  • 1.07%
  • 2.59%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 50.27
  • 7.24
  • 3.97

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 45.57
  • 9.91
  • 5.77

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -46.55
  • -44.86

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.42
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.95
  • 0.96
  • 1.29

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.13
  • 11.25
  • 12.70

Earnings Forecasts:

(Updated: 16-09-2025)
Description
2024
2025
2026
2027
Adj EPS
0.21
P/E Ratio
1270.48
Revenue
2711.5
EBITDA
480.46
Net Income
3.24
ROA
0.03
P/B Ratio
0.72
ROE
0.06
FCFF
9.74
FCFF Yield
0.16
Net Debt
1856.49
BVPS
371.91

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
708.05
523.78
35.18%
716.34
654.71
9.41%
682.34
651.09
4.80%
789.04
586.59
34.51%
Expenses
567.37
494.81
14.66%
563.65
592.03
-4.79%
542.21
609.98
-11.11%
641.89
525.74
22.09%
EBITDA
140.68
28.97
385.61%
152.69
62.68
143.60%
140.13
41.11
240.87%
147.15
60.85
141.82%
EBIDTM
19.87%
5.53%
21.32%
9.57%
20.54%
6.31%
18.65%
10.37%
Other Income
24.75
1.43
1,630.77%
7.97
7.16
11.31%
5.63
6.05
-6.94%
6.65
8.47
-21.49%
Interest
42.76
31.93
33.92%
42.12
30.95
36.09%
48.78
33.08
47.46%
36.63
27.49
33.25%
Depreciation
81.35
70.59
15.24%
79.09
85.00
-6.95%
71.97
80.37
-10.45%
72.09
75.04
-3.93%
PBT
38.67
-77.56
-
27.70
-49.20
-
27.05
-66.29
-
42.12
-36.26
-
Tax
15.26
0.01
1,52,500.00%
-15.39
20.72
-
22.42
-6.66
-
9.03
4.64
94.61%
PAT
23.41
-77.57
-
43.09
-69.92
-
4.63
-59.63
-
33.09
-40.90
-
PATM
3.31%
-14.81%
6.02%
-10.68%
0.68%
-9.16%
4.19%
-6.97%
EPS
1.49
-4.95
-
2.75
-4.46
-
0.30
-3.80
-
2.11
-2.61
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
2,895.77
2,711.50
2,615.77
2,412.92
2,140.69
1,912.03
2,043.60
2,058.60
1,694.79
1,713.69
Net Sales Growth
19.85%
3.66%
8.41%
12.72%
11.96%
-6.44%
-0.73%
21.47%
-1.10%
 
Cost Of Goods Sold
533.39
501.64
597.19
516.82
447.42
468.15
458.72
403.78
336.93
329.30
Gross Profit
2,362.38
2,209.86
2,018.58
1,896.10
1,693.27
1,443.88
1,584.88
1,654.82
1,357.86
1,384.39
GP Margin
81.58%
81.50%
77.17%
78.58%
79.10%
75.52%
77.55%
80.39%
80.12%
80.78%
Total Expenditure
2,315.12
2,271.77
2,351.85
2,080.72
1,815.04
1,637.82
1,546.04
1,506.70
1,256.77
1,260.34
Power & Fuel Cost
-
92.20
104.29
87.57
62.58
41.28
60.26
56.79
48.67
49.74
% Of Sales
-
3.40%
3.99%
3.63%
2.92%
2.16%
2.95%
2.76%
2.87%
2.90%
Employee Cost
-
1,293.57
1,208.16
1,029.86
981.49
872.91
762.27
714.64
625.40
596.02
% Of Sales
-
47.71%
46.19%
42.68%
45.85%
45.65%
37.30%
34.71%
36.90%
34.78%
Manufacturing Exp.
-
166.79
209.66
171.92
144.91
118.31
118.03
114.69
83.69
98.02
% Of Sales
-
6.15%
8.02%
7.12%
6.77%
6.19%
5.78%
5.57%
4.94%
5.72%
General & Admin Exp.
-
157.05
159.87
142.69
104.71
82.76
90.42
157.80
112.15
81.58
% Of Sales
-
5.79%
6.11%
5.91%
4.89%
4.33%
4.42%
7.67%
6.62%
4.76%
Selling & Distn. Exp.
-
32.72
24.80
35.47
29.44
21.94
23.40
20.90
18.56
58.54
% Of Sales
-
1.21%
0.95%
1.47%
1.38%
1.15%
1.15%
1.02%
1.10%
3.42%
Miscellaneous Exp.
-
27.80
47.88
96.39
44.49
32.47
32.94
38.10
31.37
47.14
% Of Sales
-
1.03%
1.83%
3.99%
2.08%
1.70%
1.61%
1.85%
1.85%
2.75%
EBITDA
580.65
439.73
263.92
332.20
325.65
274.21
497.56
551.90
438.02
453.35
EBITDA Margin
20.05%
16.22%
10.09%
13.77%
15.21%
14.34%
24.35%
26.81%
25.85%
26.45%
Other Income
45.00
50.89
50.79
27.77
49.14
38.59
44.46
53.82
53.02
26.13
Interest
170.29
159.46
119.97
85.69
56.81
47.61
61.95
56.55
48.83
49.01
Depreciation
304.50
293.74
310.86
280.72
307.59
307.94
282.87
240.38
211.42
213.50
PBT
135.54
37.42
-116.12
-6.44
10.39
-42.75
197.20
308.79
230.79
216.97
Tax
31.32
16.07
31.19
-24.79
-22.26
100.10
38.69
98.46
76.22
70.65
Tax Rate
23.11%
83.22%
-25.51%
45.41%
523.76%
-153.93%
19.62%
31.89%
33.03%
32.56%
PAT
104.22
3.24
-153.45
-29.80
18.01
-165.13
158.51
210.33
154.57
146.32
PAT before Minority Interest
104.22
3.24
-153.45
-29.80
18.01
-165.13
158.51
210.33
154.57
146.32
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.60%
0.12%
-5.87%
-1.24%
0.84%
-8.64%
7.76%
10.22%
9.12%
8.54%
PAT Growth
142.02%
-
-
-
-
-
-24.64%
36.07%
5.64%
 
EPS
6.65
0.21
-9.79
-1.90
1.15
-10.53
10.11
13.41
9.86
9.33

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
5,831.52
5,627.50
5,809.67
5,548.94
5,698.82
5,715.06
5,379.09
5,107.33
4,813.98
Share Capital
31.36
31.36
31.36
31.36
31.36
31.38
32.28
32.28
0.00
Total Reserves
5,800.16
5,596.14
5,778.31
5,517.58
5,667.46
5,683.68
5,346.81
5,075.05
3.98
Non-Current Liabilities
2,230.03
1,388.40
1,831.43
1,665.47
1,366.74
909.40
743.13
883.95
766.66
Secured Loans
1,129.02
245.61
1,046.65
761.96
503.94
222.41
310.55
386.16
241.45
Unsecured Loans
20.17
0.00
0.00
0.00
0.00
18.89
51.87
138.81
218.67
Long Term Provisions
352.43
379.04
233.16
277.09
310.99
294.08
248.31
234.34
221.40
Current Liabilities
1,924.79
2,554.72
1,798.39
1,419.79
1,290.30
1,568.95
1,198.31
1,177.72
993.66
Trade Payables
230.68
244.12
219.73
193.37
169.23
283.52
194.57
185.92
85.64
Other Current Liabilities
993.23
639.53
841.64
702.41
558.68
578.83
430.36
515.88
457.19
Short Term Borrowings
655.35
1,620.23
680.76
492.64
542.47
688.23
520.09
393.31
384.95
Short Term Provisions
45.53
50.84
56.26
31.37
19.92
18.37
53.29
82.61
65.88
Total Liabilities
9,986.34
9,570.62
9,439.49
8,634.20
8,355.86
8,193.41
7,320.53
7,169.00
6,574.30
Net Block
7,050.72
6,720.08
6,183.17
5,768.14
5,693.34
5,672.85
5,092.37
5,060.70
4,847.25
Gross Block
10,545.34
10,308.48
9,457.72
8,633.43
8,155.29
7,890.70
6,896.88
6,621.19
6,187.07
Accumulated Depreciation
3,494.62
3,588.40
3,274.55
2,865.29
2,461.95
2,217.85
1,804.51
1,560.49
1,339.82
Non Current Assets
7,785.92
7,642.43
7,521.13
6,795.48
6,651.72
6,414.44
5,766.95
5,622.85
5,241.25
Capital Work in Progress
466.84
645.74
1,043.25
779.51
485.78
234.17
175.25
150.71
132.88
Non Current Investment
71.96
78.85
72.10
31.83
55.78
89.09
152.61
106.60
44.25
Long Term Loans & Adv.
190.47
192.78
217.24
210.78
411.53
412.88
345.40
299.33
200.63
Other Non Current Assets
1.79
0.66
0.81
0.66
0.35
5.45
1.32
5.51
16.24
Current Assets
2,200.42
1,928.19
1,918.36
1,838.72
1,704.14
1,778.97
1,553.58
1,546.15
1,333.05
Current Investments
25.43
23.29
176.97
292.53
116.44
106.61
19.72
94.35
0.00
Inventories
900.24
882.89
803.80
645.12
515.65
580.87
548.62
484.56
426.58
Sundry Debtors
665.14
484.47
589.91
473.42
420.71
577.43
445.30
444.40
285.55
Cash & Bank
507.03
413.35
189.17
172.09
307.74
160.98
95.67
69.06
87.39
Other Current Assets
102.58
45.15
37.54
66.08
343.60
353.08
444.27
453.78
533.53
Short Term Loans & Adv.
80.17
79.04
120.97
189.48
197.57
277.10
309.17
373.27
361.20
Net Current Assets
275.63
-626.53
119.97
418.93
413.84
210.02
355.27
368.43
339.39
Total Assets
9,986.34
9,570.62
9,439.49
8,634.20
8,355.86
8,193.41
7,320.53
7,169.00
6,574.30

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
375.23
379.43
265.95
354.85
512.66
585.14
282.03
226.44
302.65
PBT
19.31
-122.26
-54.59
-4.25
-65.03
197.20
308.79
230.79
216.08
Adjustment
466.83
376.83
392.46
325.36
312.54
330.11
277.24
235.49
231.80
Changes in Working Capital
-80.59
143.83
-37.73
90.08
316.35
132.23
-174.47
-206.26
-29.43
Cash after chg. in Working capital
405.55
398.40
300.14
411.19
563.86
659.54
411.56
260.02
418.45
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-30.32
-18.97
-34.19
-56.34
-51.20
-74.40
-129.53
-33.58
-115.80
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-192.21
-229.52
-494.08
-618.53
-380.02
-441.74
-169.02
-297.16
-142.41
Net Fixed Assets
-16.28
-47.06
-143.00
28.96
-52.16
-76.56
-15.68
-66.76
Net Investments
7.27
64.69
119.43
-150.57
18.40
6.58
30.41
-175.91
Others
-183.20
-247.15
-470.51
-496.92
-346.26
-371.76
-183.75
-54.49
Cash from Financing Activity
-102.09
-22.15
249.68
130.37
-11.04
-97.78
-102.20
77.63
-137.08
Net Cash Inflow / Outflow
80.93
127.76
21.55
-133.31
121.60
45.62
10.81
6.91
23.16
Opening Cash & Equivalents
264.09
131.79
110.24
243.55
121.94
76.32
65.52
58.61
0.00
Closing Cash & Equivalent
341.07
264.09
131.79
110.24
243.54
121.94
76.33
65.52
58.61

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
371.91
358.90
370.51
353.89
363.45
364.25
333.28
316.44
0.00
ROA
0.03%
-1.61%
-0.33%
0.21%
-2.00%
2.04%
2.90%
2.25%
2.23%
ROE
0.06%
-2.68%
-0.52%
0.32%
-2.89%
2.86%
4.01%
6.05%
3676.38%
ROCE
2.31%
-0.03%
0.43%
0.76%
-0.26%
3.93%
5.79%
4.67%
4.61%
Fixed Asset Turnover
0.26
0.26
0.27
0.26
0.24
0.28
0.30
0.26
0.28
Receivable days
77.38
74.96
80.42
76.23
95.27
91.33
78.87
78.60
60.82
Inventory Days
120.02
117.68
109.59
98.96
104.66
100.87
91.59
98.11
90.86
Payable days
172.74
141.75
145.87
147.90
176.50
49.83
43.67
37.47
22.81
Cash Conversion Cycle
24.66
50.89
44.14
27.28
23.44
142.37
126.80
139.24
128.86
Total Debt/Equity
0.36
0.35
0.31
0.26
0.20
0.18
0.19
0.21
238.62
Interest Cover
1.12
-0.02
0.36
0.93
-0.37
4.18
6.46
5.73
5.43

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018

News Update:


  • Dishman Carbogen Amcis receives EIR from USFDA
    28th Aug 2025, 12:59 PM

    The company has secured Establishment Inspection Report for its Naroda facility

    Read More
  • Dishman Carbogen Amc - Quarterly Results
    12th Aug 2025, 22:44 PM

    Read More
  • USFDA completes inspection at Dishman Carbogen Amcis’ facility in Naroda
    16th Jun 2025, 09:48 AM

    The inspection was concluded without any observation or issuance of form 483’s, confirming that no concerns were discovered during the inspection

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.